EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -1.298
March 31, 2026 -1.620
December 31, 2025 -1.882
September 30, 2025 -4.165
June 30, 2025 -3.857
March 31, 2025 -3.163
December 31, 2024 -2.425
September 30, 2024 -0.0967
June 30, 2024 -0.0819
March 31, 2024 -0.1288
December 31, 2023 -0.1454
September 30, 2023 -0.129
June 30, 2023 -0.0946
March 31, 2023 -0.2256
December 31, 2022 -0.2636
September 30, 2022 -0.2291
June 30, 2022 -0.2495
March 31, 2022 -0.0559
December 31, 2021 0.0189
September 30, 2021 -0.0052
June 30, 2021 0.0101
March 31, 2021 0.0018
December 31, 2020 -0.051
September 30, 2020 -0.0456
June 30, 2020 -0.0377
Date Value
March 31, 2020 -0.0543
December 31, 2019 -0.0725
September 30, 2019 -0.1967
June 30, 2019 -0.2698
March 31, 2019 -0.3828
December 31, 2018 -0.3882
September 30, 2018 -0.363
June 30, 2018 -0.3203
March 31, 2018 -0.2528
December 31, 2017 -0.2488
September 30, 2017 -0.2589
June 30, 2017 -0.2924
March 31, 2017 -0.3084
December 31, 2016 -0.3822
September 30, 2016 -0.4103
June 30, 2016 -0.5157
March 31, 2016 -0.7918
December 31, 2015 -0.81
September 30, 2015 -0.8001
June 30, 2015 -0.7919
March 31, 2015 -0.3653
December 31, 2014 -0.3536
September 30, 2014 -0.335
June 30, 2014 -0.4533
March 31, 2014 -0.7904

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 6.826
Cellectis SA -0.6502
Alkermes Plc 0.385
Akari Therapeutics Plc -19.78
Liquidia Corp. 1.364